Resource Details


NICE - Interferon alfa (pegylated and non-pegylated) and ribavarin for the treatment of chronic Hepatitis C

Author(s)National Institute for Health and Clinical Excellence
AbstractThe review and re-appraisal of previous guidance issued in 2000 has resulted in an extension to the guidance; combination therapy with pegylated interferon alfa and ribavirin is recommended for the treatment of people aged 18 years and over with moderate to severe chronic hepatitis C.
Date of publishing01/28/2004
Date of last review by us10/26/2005
Bookmark this page Email this page to a friend Print this page



Twitter FeedTwitter Feed